Somatomedin-C and platelet-derived growth factor stimulate human fibroblast replication

✍ Scribed by David R. Clemmons; Judson J. Van Wyk

• Publisher: John Wiley and Sons
• Year: 1981
• Tongue: English
• Weight: 665 KB
• Volume: 106
• Category: Article
• ISSN: 0021-9541
• DOI: 10.1002/jcp.1041060305

✦ Synopsis

Abstract

Previous studies have demonstrated that serum contains mitogens, such as platelet‐derived growth factor (PDGF), which may alter fibroblast responsiveness to growth factors contained in plasma. Somatomedin‐C (SM‐C) has been identified as one of the plasma growth factors required for mouse Balb/c 3T3 fibroblasts to initiate DNA synthesis. The present experiments were undertaken to explore the interaction between PDGF, human growth hormone (hGH), SM‐C, and other growth‐promoting agents in stimulating the growth of human fibroblasts. Proliferation of human dermal fibroblasts plated at low density (3,000 cells/cm^2^) was found to be equally stimulated by continuous exposure to either normal or somatomedin‐C‐deficient serum. In contrast, when confluent monolayers were sequentially exposed to PDGF, followed either by normal platelet poor plasma (PPP) or hypopituitary PPP, the cells exposed to normal PPP entered the “S” phase of the cell cycle 50% faster. This difference could be abolished by a 6‐hour incubation with growth hormone (10 ng/ml) or somatomedin‐C (5 ng/ml) preceding the addition of plasma. When medium containing either hGH or Sm‐C was changed frequently so as to remove factors secreted by fibroblasts, only those cells exposed to exogenous somatomedin‐C entered DNA synthesis. This finding is in agreement with previous findings that human fibroblasts are capable of making Sm‐C in response to hGH. These findings support the hypothesis that somatomedin is required for fibroblast replication in vitro, and that growth hormone appears to stimulate replication indirectly through somatomedin production.